MMP2 and neoplasm: A selective MMP2 inhibitor (a novel peptide CCKIGLFRWR) was linked with doxorubicin (DOX) to produce an amphiphilic peptide-drug nanoparticle which can inhibit tumor metastasis and augment treatment efficacy (Qian et al., 2020).